PepsiCo is expanding its reusable cup program at the Super Bowl and leveraging AI to support recycling efforts at Super Bowl events. The reuseable cups are made from BPA-free polypropylene and hold 32 ...

Vice President JD Vance announced a new push on Wednesday to create price stability in the market for critical rare earth minerals and said he wants to use a familiar Trump-world tool to accomplish it ...

Elon Musk's rocket maker SpaceX has acquired artificial intelligence startup xAI in a deal that will value the company at $1.25 trillion, CNBC has confirmed. The transaction comes ahead of a potential ...

Now that generative artificial intelligence tools have been widely implemented in retirement planning, experts suggest advisers turn to embedded AI to ramp up efficiency. Generative artificial ...

Participating Medicare Part D plans can officially begin covering weight-loss treatment in 2027. The initiative falls under CMS’ voluntary “Better Approaches to Lifestyle and Nutrition for ...

Musk could be consolidating his companies. Musk could be consolidating his companies. is a senior reporter covering technology, gaming, and more. He joined The Verge in 2019 after nearly two years at ...

On the Wednesday, January 28, 2026, episode of The Excerpt podcast: As GLP-1 use surges, lawsuits allege blindness, stomach paralysis and more. USA TODAY Investigative Reporter Austin Fast breaks down ...

Once exclusively a treatment for diabetes, GLP-1 medications have gone mainstream — forcing restaurants to adjust to changing appetites and nutrition needs. As GLP-1 medications normalize smaller ...

Just when you thought the circular deals couldn’t get any more circular, OpenAI has invested in CEO Sam Altman’s brain computer interface (BCI) startup Merge Labs. Merge Labs, which defines itself as ...

On Thursday, OpenAI announced its investment in neurotech startup Merge Labs, cofounded by its CEO, billionaire Sam Altman. OpenAI will collaborate with the new venture to develop technology to link ...

For women with obesity, GLP-1 medications like Ozempic and Wegovy may help address the metabolic challenges that often intensify during midlife. The hormonal shifts of perimenopause and menopause can ...

The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like peptide-1 (GLP-1) agonists regain the pounds at a steady rate, returning to ...